Announce Date | 05/29/2024 |
EPS Normalized Actual | $0.82 (Beat by $0.0089999999999999) |
EPS GAAP Actual | $0.82 (Beat by $0.0089999999999999) |
Revenue Actual | $16.49B |
Revenue Surprise | Beat by $16490M |
Announce Date | 07/30/2024 (Pre-Market) |
EPS Normalized Estimate | $0.85977 |
EPS GAAP Estimate | $0.85977 |
Revenue Estimate | $13.580631713B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2026 | 3.16 | 11.81 | 3.16 | 3.16 | 1 |
Oct 2025 | 3.22048 | 11.59 | 2.73 | 3.56193 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (Apr 2022) | 0.95 | 0.95 | 16.49B | 3.72% | 16490M |
FQ1 2022 (Jan 2022) | 1 | 1 | 17.028B | 8.12% | 17028M |
FQ4 2021 (Oct 2021) | 2.75 | 2.75 | 16.675B | 8.5% | 16675M |
FQ3 2021 (Jul 2021) | 0.94 | 0.94 | 15.289B | 6.51% | 15289M |
FQ2 2021 (Apr 2021) | 1 | 1 | 15.877B | 21.47% | 15877M |
FQ1 2021 (Jan 2021) | 0.83 | 0.83 | 15.646B | 6.57% | 15646M |
FQ4 2020 (Oct 2020) | 0.5 | 0.5 | 15.258B | -0.98% | 15258M |
FQ3 2020 (Jul 2020) | 0.52 | 0.52 | 14.294B | -2.16% | 14294M |
FQ4 Announce Date
07/30/2024 (Pre-Market)
Consensus EPS Estimates
0.85977
Consensus Revenue Estimates
13.580631713B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.0082 | -- | 0.98734 | 1.03277 | 5 |
FQ3 2026 (Jul 2026) | 0.9102 | -- | 0.89137 | 0.93238 | 2 |
FQ2 2026 (Apr 2026) | 0.94052 | -- | 0.92106 | 0.96344 | 2 |
FQ1 2026 (Jan 2026) | 0.88931 | -- | 0.86879 | 0.91409 | 2 |
FQ4 2025 (Oct 2025) | 0.97169 | -- | 0.95158 | 0.99537 | 3 |
FQ3 2025 (Jul 2025) | 0.91055 | -- | 0.89171 | 0.93274 | 3 |
FQ2 2025 (Apr 2025) | 0.88643 | -- | 0.86809 | 0.90803 | 4 |
FQ1 2025 (Jan 2025) | 0.8893 | -- | 0.86878 | 0.91408 | 4 |
FQ4 2024 (Oct 2024) | 0.93864 | -- | 0.91922 | 0.96151 | 4 |
FQ3 2024 (Jul 2024) | 0.85977 | -- | 0.83978 | 0.88976 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 14.65B | -- | 14.42B | 14.93B | 3 |
FQ3 2026 (Jul 2026) | 13.76B | -- | 13.54B | 14.01B | 3 |
FQ2 2026 (Apr 2026) | 13.26B | -- | 13.05B | 13.51B | 3 |
FQ1 2026 (Jan 2026) | 14.1B | -- | 13.85B | 14.4B | 3 |
FQ4 2025 (Oct 2025) | 14.57B | -- | 14.33B | 14.84B | 3 |
FQ3 2025 (Jul 2025) | 13.79B | -- | 13.57B | 14.04B | 3 |
FQ2 2025 (Apr 2025) | 13.45B | -- | 13.24B | 13.71B | 3 |
FQ1 2025 (Jan 2025) | 13.9B | -- | 13.65B | 14.2B | 2 |
FQ4 2024 (Oct 2024) | 14.33B | -- | 14.11B | 14.6B | 3 |
FQ3 2024 (Jul 2024) | 13.58B | -- | 13.42B | 13.66B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | 0.95 | 0.95 | 100% | |
FQ1 2022 (Jan 2022) | 1 | 1 | 100% | |
FQ4 2021 (Oct 2021) | 2.75 | 2.75 | 100% | |
FQ3 2021 (Jul 2021) | 0.94 | 0.94 | 100% | |
FQ2 2021 (Apr 2021) | 1 | 1 | 100% | |
FQ1 2021 (Jan 2021) | 0.83 | 0.83 | 100% | |
FQ4 2020 (Oct 2020) | 0.5 | 0.5 | 100% | |
FQ3 2020 (Jul 2020) | 0.52 | 0.52 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | $0B | $16.49B | $16490M | 100% |
FQ1 2022 (Jan 2022) | $0B | $17.03B | $17028M | 100% |
FQ4 2021 (Oct 2021) | $0B | $16.68B | $16675M | 100% |
FQ3 2021 (Jul 2021) | $0B | $15.29B | $15289M | 100% |
FQ2 2021 (Apr 2021) | $0B | $15.88B | $15877M | 100% |
FQ1 2021 (Jan 2021) | $0B | $15.65B | $15646M | 100% |
FQ4 2020 (Oct 2020) | $0B | $15.26B | $15258M | 100% |
FQ3 2020 (Jul 2020) | $0B | $14.29B | $14294M | 100% |